Comment on: Benchmarking tocilizumab use for giant cell arteritis
(2022)
Journal Article
Janagan, S., Guly, C., Skeoch, S., & Robson, J. C. (2022). Comment on: Benchmarking tocilizumab use for giant cell arteritis. Rheumatology Advances in Practice, 6(3), Article rkac069. https://doi.org/10.1093/rap/rkac069
It is with great interest we read the editorial on tocilizumab (TCZ) use in giant cell arteritis (GCA) published on 9th May, 2022 by Conway et al [1]. We write to share some of our data to add weight to the views expressed, particularly in relation t... Read More about Comment on: Benchmarking tocilizumab use for giant cell arteritis.